This thesis focused on developing controlled delivery technologies to address both therapeutic and diagnostic applications. In the area of therapeutics, controlled delivery of anti-cancer agents to tumor sites have the potential to increase efficacy and decrease toxic side effects. With regard to diagnostics, controlled delivery of the target molecule, as well as signal enhancement reagents, to a detection zone can improve detection limits and further distinguish the difference between the signal and the background.